Project Grant K01DA063441
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$182K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Maryland, EE. UU.
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and assessment of a behavioral economic intervention to improve HIV-related behaviors among sexual minority men (SMM). The $264,091 award, effective September 15, 2024, aims to refine and evaluate the feasibility and acceptability of an Episodic Future Thinking (EFT) intervention delivered via smartphone to address delayed...
This $4.9 million project grant from the National Institutes of Health's National Institute on Drug Abuse will support research at The Johns Hopkins University from April 2022 to March 2026. The grant is part of the Drug Abuse and Addiction Research Programs (CFDA 93.279), which aims to develop new knowledge around prevention, diagnosis, treatment and causes of drug abuse and addiction. Specifically, the university will leverage rare longitudinal social and spatial network data along with...
This federal Project Grant award, with ID R01DA059503, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,192,612 grant will fund a 5-year research project by The Miriam Hospital, a non-profit healthcare and research institution in Providence, RI, to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives of this multidisciplinary research...
This Project Grant award of $364,832 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a mentored career development project entitled "Using Implementation Science to Enhance HIV Prevention for Young Men Who Have Sex with Men." The project aims to deliver and evaluate an enhanced care intervention called "HIV Prevention Plus Care (HP+ Care)" at two clinics, which will include motivational...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
This Project Grant award of $606,924, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 2-year research study entitled "CHAMPION - Combining HIV and Stimulant Prevention and Treatment Interventions Optimized for HIV-Negative MSM." The study aims to evaluate the feasibility, acceptability, and preliminary efficacy of a mobile health intervention package that combines a PrEP adherence app with virtual...
This $194,098 Project Grant award under the National Institute on Drug Abuse's (NIDA) Drug Use and Addiction Research Programs (CFDA 93.279) is designed to provide the principal investigator, Dr. Erath, with mentored training in implementation science to become an independent investigator focused on advancing the implementation of evidence-based treatments for stimulant use disorder and other substance use disorders in harm reduction and community treatment settings. The key objectives of the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $405,490 to the University of Georgia Research Foundation, Inc. to characterize chemsex patterns and the adoption of harm reduction measures among men in the southern United States. The key objectives of this 2-year project are to: (1) conduct in-depth interviews with 30 men to examine features of chemsex, such as drug use, sexual...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,681,276 to the Research Foundation of the City University of New York (RFCUNY) to conduct research on optimizing long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) strategies for sexual minority men (SMM) who use methamphetamine. The study aims to qualitatively identify modifiable care options for LAI PrEP use through rapid interviews,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to increase HIV and substance use prevention and treatment among adolescent and young adult (AYA) survivors of sexual violence. The $1,344,412 award will fund a 3-year project to: 1) tailor existing Sexual Assault Nurse Examiner (SANE) services with same-day HIV prophylaxis and substance use prevention, 2) optimize study mechanisms and outcome...